☰

Peter Jones - Publications

Affiliations: 
 
Tree Info Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Robinson J, Jones PM, Whitt E. EXPRESS: Excitotoxic lesions of the perirhinal cortex leave intact rats' gustatory sensory preconditioning. Quarterly Journal of Experimental Psychology (2006). 17470218211054981. PMID 34623212 DOI: 10.1177/17470218211054981  0.782
2017 Robinson J, Whitt EJ, Jones PM. Familiarity-based stimulus generalization of conditioned suppression. Journal of Experimental Psychology. Animal Learning and Cognition. 43: 159-170. PMID 28383938 DOI: 10.1037/Xan0000134  0.793
2016 Jones PH, Bays HE, Chaudhari U, Pordy R, Lorenzato C, Miller K, Robinson JG. Safety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 Randomized Trials. The American Journal of Cardiology. PMID 27729106 DOI: 10.1016/j.amjcard.2016.08.072  0.583
2015 Dumont JR, Jones PM, Pearce JM, Kosaki Y. Evidence for concrete but not abstract representation of length during spatial learning in rats. Journal of Experimental Psychology. Animal Learning and Cognition. 41: 91-104. PMID 25706549 DOI: 10.1037/Xan0000044  0.79
2015 Jones PM, Pearce JM. The fate of redundant cues: Further analysis of the redundancy effect. Learning & Behavior. 43: 72-82. PMID 25537840 DOI: 10.3758/S13420-014-0162-X  0.65
2014 Robinson JG, Colhoun HM, Bays HE, Jones PH, Du Y, Hanotin C, Donahue S. Efficacy and safety of alirocumab as add-on therapy in high-cardiovascular-risk patients with hypercholesterolemia not adequately controlled with atorvastatin (20 or 40 mg) or rosuvastatin (10 or 20 mg): design and rationale of the ODYSSEY OPTIONS Studies. Clinical Cardiology. 37: 597-604. PMID 25269777 DOI: 10.1002/clc.22327  0.569
2013 Haselgrove M, Tam SK, Jones PM. Enhanced unblocking from sustained post-trial surprise. Journal of Experimental Psychology. Animal Behavior Processes. 39: 311-22. PMID 23688285 DOI: 10.1037/A0032569  0.79
2013 Jones PM, Haselgrove M. Blocking and associability change. Journal of Experimental Psychology. Animal Behavior Processes. 39: 249-58. PMID 23668185 DOI: 10.1037/A0032254  0.792
2013 Kosaki Y, Jones PM, Pearce JM. Asymmetry in the discrimination of length during spatial learning. Journal of Experimental Psychology. Animal Behavior Processes. 39: 342-56. PMID 23668184 DOI: 10.1037/A0032570  0.791
2013 Jones PM, Haselgrove M. Overshadowing and associability change: examining the contribution of differential stimulus exposure. Learning & Behavior. 41: 107-17. PMID 22956344 DOI: 10.3758/S13420-012-0089-Z  0.8
2012 Jones PM, Whitt EJ, Robinson J. Excitotoxic perirhinal cortex lesions leave stimulus-specific habituation of suppression to lights intact. Behavioural Brain Research. 229: 365-71. PMID 22289200 DOI: 10.1016/J.Bbr.2012.01.033  0.781
2012 Jones PM, Haselgrove M. "Overshadowing and associability change": Correction to Jones and Haselgrove (2011). Journal of Experimental Psychology: Animal Behavior Processes. 38: 65-65. DOI: 10.1037/A0026749  0.723
2011 Jones PM, Haselgrove M. Overshadowing and associability change. Journal of Experimental Psychology. Animal Behavior Processes. 37: 287-99. PMID 21500931 DOI: 10.1037/A0023140  0.794
2011 Dwyer DM, Haselgrove M, Jones PM. Cue interactions in flavor preference learning: a configural analysis. Journal of Experimental Psychology. Animal Behavior Processes. 37: 41-57. PMID 21261414 DOI: 10.1037/A0021033  0.784
2011 Arbuckle W, Baugh M, Belshaw S, Bennett DJ, Bruin J, Cai J, Cameron KS, Claxton C, Dempster M, Everett K, Fradera X, Hamilton W, Jones PS, Kinghorn E, Long C, et al. 1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors: separation of desired cellular activity from undesired tissue accumulation through optimization of basic nitrogen pka. Bioorganic & Medicinal Chemistry Letters. 21: 932-5. PMID 21227690 DOI: 10.1016/j.bmcl.2010.12.065  0.594
2011 Dwyer DM, Haselgrove M, Jones PM. "Cue interactions in flavor preference learning: A configural analysis": Correction to Dwyer et al. (2011). Journal of Experimental Psychology: Animal Behavior Processes. 37: 188-188. DOI: 10.1037/A0023248  0.747
2010 Cai J, Robinson J, Belshaw S, Everett K, Fradera X, van Zeeland M, van Berkom L, van Rijnsbergen P, Popplestone L, Baugh M, Dempster M, Bruin J, Hamilton W, Kinghorn E, Westwood P, ... ... Jones PS, et al. Trifluoromethylphenyl as P2 for ketoamide-based cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 20: 6890-4. PMID 21030256 DOI: 10.1016/j.bmcl.2010.10.012  0.586
2010 Robinson J, Whitt EJ, Horsley RR, Jones PM. Familiarity-based stimulus generalization of conditioned suppression in rats is dependent on the perirhinal cortex. Behavioral Neuroscience. 124: 587-99. PMID 20939659 DOI: 10.1037/A0020900  0.788
2010 Rankovic Z, Cai J, Kerr J, Fradera X, Robinson J, Mistry A, Finlay W, McGarry G, Andrews F, Caulfield W, Cumming I, Dempster M, Waller J, Arbuckle W, Anderson M, ... ... Jones P, et al. Optimisation of 2-cyano-pyrimidine inhibitors of cathepsin K: improving selectivity over hERG. Bioorganic & Medicinal Chemistry Letters. 20: 6237-41. PMID 20843687 DOI: 10.1016/j.bmcl.2010.08.101  0.583
2010 Haselgrove M, Esber GR, Pearce JM, Jones PM. Two kinds of attention in Pavlovian conditioning: evidence for a hybrid model of learning. Journal of Experimental Psychology. Animal Behavior Processes. 36: 456-70. PMID 20718552 DOI: 10.1037/A0018528  0.767
2010 Cai J, Baugh M, Black D, Long C, Jonathan Bennett D, Dempster M, Fradera X, Gillespie J, Andrews F, Boucharens S, Bruin J, Cameron KS, Cumming I, Hamilton W, Jones PS, et al. 6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 20: 4350-4. PMID 20598883 DOI: 10.1016/j.bmcl.2010.06.072  0.589
2007 Jones PM, Pearce JM, Davies VJ, Good MA, McGregor A. Impaired processing of local geometric features during navigation in a water maze following hippocampal lesions in rats. Behavioral Neuroscience. 121: 1258-71. PMID 18085879 DOI: 10.1037/0735-7044.121.6.1258  0.75
2006 McGregor A, Jones PM, Good MA, Pearce JM. Further evidence that rats rely on local rather than global spatial information to locate a hidden goal: reply to Cheng and Gallistel (2005). Journal of Experimental Psychology. Animal Behavior Processes. 32: 314-21. PMID 16834498 DOI: 10.1037/0097-7403.32.3.314  0.753
2006 Pearce JM, Graham M, Good MA, Jones PM, McGregor A. Potentiation, overshadowing, and blocking of spatial learning based on the shape of the environment. Journal of Experimental Psychology. Animal Behavior Processes. 32: 201-14. PMID 16834489 DOI: 10.1037/0097-7403.32.3.201  0.763
2004 Pearce JM, Good MA, Jones PM, McGregor A. Transfer of spatial behavior between different environments: implications for theories of spatial learning and for the role of the hippocampus in spatial learning. Journal of Experimental Psychology. Animal Behavior Processes. 30: 135-47. PMID 15078123 DOI: 10.1037/0097-7403.30.2.135  0.772
2003 Andrews DM, Barnes MC, Dowle MD, Hind SL, Johnson MR, Jones PS, Mills G, Patikis A, Pateman TJ, Redfern TJ, Robinson JE, Slater MJ, Trivedi N. Pyrrolidine-5,5-trans-lactams. 5. Pharmacokinetic optimization of inhibitors of hepatitis C virus NS3/4A protease. Organic Letters. 5: 4631-4. PMID 14627401 DOI: 10.1021/ol035827n  0.591
2003 Andrews DM, Chaignot HM, Coomber BA, Dowle MD, Hind SL, Johnson MR, Jones PS, Mills G, Patikis A, Pateman TJ, Robinson JE, Slater MJ, Trivedi N. The design of potent, non-peptidic inhibitors of hepatitis C protease. European Journal of Medicinal Chemistry. 38: 339-43. PMID 12750019  0.585
2002 Andrews DM, Chaignot H, Coomber BA, Good AC, Hind SL, Johnson MR, Jones PS, Mills G, Robinson JE, Skarzynski T, Slater MJ, Somers DO. Pyrrolidine-5,5-trans-lactams. 2. The use of X-ray crystal structure data in the optimization of P3 and P4 substituents. Organic Letters. 4: 4479-82. PMID 12465917 DOI: 10.1021/ol027014p  0.584
2002 Andrews DM, Carey SJ, Chaignot H, Coomber BA, Gray NM, Hind SL, Jones PS, Mills G, Robinson JE, Slater MJ. Pyrrolidine-5,5-trans-lactams. 1. Synthesis and incorporation into inhibitors of hepatitis C virus NS3/4A protease. Organic Letters. 4: 4475-8. PMID 12465916 DOI: 10.1021/ol027013x  0.592
Show low-probability matches.